Skip to main content
NCBI home page
BMC Cancer logoLink to BMC Cancer
. 2023 Feb 27;23:192. doi: 10.1186/s12885-023-10662-3

Correction: Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy

Cengiz Karacin 1,✉, Berna Oksuzoglu 1, Ayşe Demirci 2, Merve Keskinkılıç 3, Naziyet Köse Baytemür 4, Funda Yılmaz 1, Oğuzhan Selvi 5, Dilek Erdem 6, Esin Avşar 7, Nail Paksoy 8, Necla Demir 9, Sema Sezgin Göksu 10, Sema Türker 11, Ertuğrul Bayram 12, Abdüssamet Çelebi 13, Hatice Yılmaz 14, Ömer Faruk Kuzu 15, Seda Kahraman 15, İvo Gökmen 16, Abdullah Sakin 17, Ali Alkan 18, Erdinç Nayır 19, Muzafer Uğraklı 20, Ömer Acar 21, İsmail Ertürk 22, Hacer Demir 23, Ferit Aslan 24, Özlem Sönmez 25, Taner Korkmaz 25, Özde Melisa Celayir 25, İbrahim Karadağ 26, Erkan Kayıkçıoğlu 27, Teoman Şakalar 28, İlker Nihat Öktem 29, Tülay Eren 30, Enes Erul 31, Eda Eylemer Mocan 32, Ziya Kalkan 33, Nilgün Yıldırım 34, Yakup Ergün 35, Baran Akagündüz 36, Serdar Karakaya 37, Engin Kut 38, Fatih Teker 39, Burçin Çakan Demirel 40, Kubilay Karaboyun 41, Elvina Almuradova 42, Olçun Ümit Ünal 43, Abdilkerim Oyman 44, Deniz Işık 45, Kerem Okutur 46, Buğra Öztosun 47, Burcu Belen Gülbağcı 2, Mehmet Emin Kalender 48, Elif Şahin 49, Mustafa Seyyar 49, Özlem Özdemir 50, Fatih Selçukbiricik 51, Metin Kanıtez 52, İsa Dede 53, Mahmut Gümüş 47, Erhan Gökmen 42, Arzu Yaren 40, Serkan Menekşe 38, Senar Ebinç 33, Sercan Aksoy 31, Gökşen İnanç İmamoğlu 30, Mustafa Altınbaş 30, Bülent Çetin 27, Başak Oyan Uluç 25, Özlem Er 25, Nuri Karadurmuş 22, Atike Pınar Erdoğan 21, Mehmet Artaç 20, Özgür Tanrıverdi 18, İrfan Çiçin 16, Mehmet Ali Nahit Şendur 15, Esin Oktay 14, İbrahim Vedat Bayoğlu 13, Semra Paydaş 12, Adnan Aydıner 8, Derya Kıvrak Salim 7, Çağlayan Geredeli 5, Tuğba Yavuzşen 3, Mutlu Doğan 1, İlhan Hacıbekiroğlu 2
PMCID: PMC9969671  PMID: 36849943

Correction: BMC Cancer 23, 136 (2023)

https://doi.org/10.1186/s12885-023-10609-8

Following publication of the original article [1], the authors reported an error in the author name of Enes Erul.

Incorrect: Enes Urul

Correct: Enes Erul

The original article [1] has been corrected.

Reference

  • 1.Karacin C, Oksuzoglu B, Demirci A, et al. Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy. BMC Cancer. 2023;23:136. doi: 10.1186/s12885-023-10609-8. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from BMC Cancer are provided here courtesy of BMC

RESOURCES